Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110590821A details mild iridium-catalyzed synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing with stable raw materials and high purity.
Novel one-pot synthesis of alpha-diketones from propargyl alcohols and anhydrides using metal salts. Mild conditions, high yield, cost-effective for pharma intermediates.
Patent CN118084876A reveals a concise Pauson-Khand route for indole skeletons. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Patent CN101397277A reveals a high-purity route for aminomethyl biphenyl tetrazole salts, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Novel patent CN104031043A details high-yield Moxifloxacin Hydrochloride synthesis. Delivers superior purity and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN116283880A reveals a novel Bi(OTf)3-catalyzed route for indeno[2,1,c]chromenes, offering significant cost reduction and simplified supply chain for pharmaceutical intermediates.
Advanced oxidation method for >99% pure Prothioconazole. Cost-effective, scalable agrochemical intermediate manufacturing with simplified purification.
Patent CN114605302B analysis reveals efficient rhodium catalysis for axial chirality. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN1169143A details a novel liquid-phase hydrocyanation method using multidentate phosphite ligands, offering significant cost reduction in nylon precursor manufacturing and enhanced supply chain reliability.
Novel phthalimide ionic liquid catalyst enables mild CO2 fixation. High yield 98.7%. Solvent-free process reduces cost. Reliable supplier for green chemical intermediates.
Advanced preparation method for Tebipenem Pivoxil (L-084) utilizing crystallization purification and in situ esterification to ensure high purity and cost-effective manufacturing.
Patent CN113564144A discloses lipase mutants enabling room temperature, water-phase asymmetric hydrolysis with >95% e.e., offering cost-effective pharmaceutical intermediate manufacturing.
Patent CN102167689B details a low-cost, scalable route for chiral warfarin using amine catalysis, offering significant supply chain advantages for anticoagulant manufacturing.
Patent CN111333558A details a catalyst-free visible light method for α-selenyl ketones. Discover cost-effective, scalable routes for high-purity pharmaceutical intermediates.
Advanced synthesis method for quinolinone derivatives offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability for global buyers.
Patent CN121426651A reveals TEMPO-catalyzed oxidation. Offers cost reduction in pharmaceutical intermediate manufacturing with scalable green chemistry.
Patent CN108659045A reveals a cost-effective chiral ligand synthesis. Enhance enantioselectivity and supply chain stability for pharmaceutical intermediate manufacturing with this novel approach.
Patent CN113214322B details a green preparation of Tenofovir using rare-earth doped solid super acids, offering reduced corrosion and wastewater for API manufacturers.
Patent CN111560005A details green synthesis of 2-thiopheneacetyl chloride offering high purity and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN101648978A details a novel PEG-catalyzed route for >99% purity hexaphenoxycyclotriphosphazene, offering significant cost reduction and supply chain reliability for specialty chemical manufacturers.